US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
USD 3,850
USD 4,850
USD 3,850
USD 3,850
Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update
9/1/2014 | published by: GlobalData
... cancer test, rosetta kidney cancer test and rosetta mesothelioma test. RGL product pipeline includes tests such as thyroid neoplasia, oncology project, kidney rejection, Alzheimer's disease, therapeutics and CMV. The company has distribution network in Australia, ...  |  read more...
USD 750
IntegraGen S.A (ALINT) - Product Pipeline Analysis, 2014 Update
9/1/2014 | published by: GlobalData
... selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data. IntegraGen provides sequencing and genotyping of DNA and RNA. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves ...  |  read more...
USD 750
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
8/4/2014 | published by: Roots Analysis
... more than USD 600 million in 2014. 2. About 45 molecules are currently in clinical development. Of these, approximately 25% are in Phase II or Phase III of development. As expected, the preclinical pipeline is ...  |  read more...
USD 1,899
Biomarkers in Alzheimer's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ...  |  read more...
USD 699
Microbial Identification Market Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic) Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages), End User (Detection, Characterization) - Global Forecasts to 2019
7/28/2014 | published by: MarketsandMarkets
... the basis of products, methods, applications, end users, and geographies. Genotypic technology is expected to register highest growth in the microbial identification market. This favorable growth is attributed to the decrease in consumable costs (per ...  |  read more...
USD 4,650
Baxter International Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Charles River Laboratories International, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Emergent Biosolutions, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Elan Corporation, plc: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Enzo Biochem, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Advanced Orthopedic Technologies, Implants and Regenerative Products
8/1/2014 | published by: BCC Research
... a compound annual growth rate (CAGR) of 3.0% for the period of 2014 to 2019 reaching nearly $42.2 billion in 2019. An overview of the global market for advanced orthopedic technologies, implants, and regenerative products. ...  |  read more...
USD 6,650
Tissue Engineering and Regeneration - Technologies and Global Markets
8/1/2014 | published by: BCC Research
... billion in 2019, a compound annual growth rate(CAGR) of 22.3%. This report provides: An overview of the global market for tissue engineering and regeneration, and related technologies. Analyses of global market trends, with data from ...  |  read more...
USD 6,650
G-Protein Coupled Receptor (GPCR) Targeting -Technologies and Global Markets
8/1/2014 | published by: BCC Research
... blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes ...  |  read more...
USD 6,650
Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?
8/14/2014 | published by: FirstWord
... myeloma patients, thus greatly multiplying the drug's commercial potential. In the three quarters since the deal closed, investors have put up with relatively unremarkable sales growth for Kyprolis but have been getting antsy waiting for ...  |  read more...
USD 645
Novartis Consumer Health OOO in Consumer Health (Russia)
8/15/2014 | published by: Euromonitor International
... into the establishment of manufacturing facilities in St Petersburg. The first line should be opened in 2014, and all works will be ended by the first quarter 2015. This will not only allow the company ...  |  read more...
USD 150
Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
8/14/2014 | published by: MarketsandMarkets
... exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with that ...  |  read more...
USD 4,650
Bioxyne Limited (BXN) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review
8/5/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Med BioGene Inc. (MBI) - Financial and Strategic SWOT Analysis Review
8/5/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
3  4  5  6    8    10  11  12